Eupharma Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 03	Mar ' 02	Jun ' 00

Sources of funds

Owner's fund

Equity share capital

10.00

10.00

12.50

Share application money

-

-

-

Preference share capital

-

-

-

Reserves & surplus

-18.08

-15.93

44.34

Loan funds

Secured loans

31.27

31.27

28.34

Unsecured loans

5.67

5.51

5.08

Total

28.86

30.85

90.26

Uses of funds

Fixed assets

Gross block

23.43

23.51

22.84

Less : revaluation reserve

3.69

3.75

3.86

Less : accumulated depreciation

11.38

10.44

8.34

Net block

8.36

9.32

10.64

Capital work-in-progress

0.10

0.04

7.01

Investments

1.01

1.01

1.01

Net current assets

Current assets, loans & advances

27.96

29.39

89.82

Less : current liabilities & provisions

8.58

8.92

18.23

Total net current assets

19.38

20.47

71.59

Miscellaneous expenses not written

0.01

0.01

0.01

Total

28.86

30.85

90.26

Notes:

Book value of unquoted investments

-

-

1.01

Market value of quoted investments

-

-

-

Contingent liabilities

5.08

5.08

1.01

Number of equity sharesoutstanding (Lacs)

100.00

100.00

200.00